Potentially inappropriate prescribing in Canada relative to the US

Drugs and Aging

Volumn 21, Issue 14, 2004, Pages 939-947

  Rochon, Paula A ^a,e   Lane, Christopher J ^a   Bronskill, Susan E ^b   Sykora, Kathy ^c   Anderson, Geoffrey M ^b   Mamdani, Muhammad M ^b   Gurwitz, Jerry H ^d   Dhalla, Irfan A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BARBITURIC ACID DERIVATIVE; BELLADONNA ALKALOID; BENZODIAZEPINE DERIVATIVE; CARISOPRODOL; CHLORDIAZEPOXIDE; CHLORPROPAMIDE; CHLORZOXAZONE; DEXTROPROPOXYPHENE; DIAZEPAM; DICYCLOVERINE; DISOPYRAMIDE; DOXEPIN; FLURAZEPAM; HYDROXYZINE; HYOSCYAMINE; INDOMETACIN; MEPROBAMATE; METAXALONE; METHOCARBAMOL; METHYLDOPA; OXYBUTYNIN; PENTAZOCINE; PETHIDINE; PROMETHAZINE; PROPANTHELINE BROMIDE; RESERPINE; TICLOPIDINE; TRIMETHOBENZAMIDE; UNINDEXED DRUG;

AGED; ANTICHOLINERGIC EFFECT; CANADA; DATA BASE; DRUG FORMULARY; DRUG HALF LIFE; DRUG SAFETY; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; STATISTICAL ANALYSIS; UNITED STATES;

AGED; AGED, 80 AND OVER; CANADA; COHORT STUDIES; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; HUMANS; MALE; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 10344224013     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200421140-00004     Document Type: Review

References (15)

1. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995; 274: 29-34
2. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289 (9): 1107-16
3. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531-6
4. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly. JAMA 2001; 286: 2823-9
5. Moeller JF, Stagnitti M, Horan E, et al. Outpatient prescription drugs: data collection and editing in the 1996 Medical Expenditure Panel Survey (HC-010A). Rockville (MD): Agency for Healthcare and Quality, 2001
6. Ontario Ministry of Health. Ontario drug benefit formulary/comparative drug index. Toronto: Ontario Ministry of Health, 1996
7. Canadian Pharmacists Association. Compendium of pharmaceuticals and specialities. Gillis MC, editor. 31st ed. Ottawa: Canadian Pharmacists Association, 1996
8. Steinman MA, Sands L, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage: a national survey. J Gen Intern Med 2001; 16: 793-9
9. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001; 285 (4): 421-9
10. Ross-Degnan D, Soumerai SB, Fortess EE, et al. Examining product risk in context: market withdrawal of zomepirac as a case study. JAMA 1993; 270 (16): 1937-42
11. Bates DW, Gawande A. Improving safety with information technology. N Engl J Med 2003; 348: 2526-34
12. Teich JM, Merchia PR, Schmiz JL, et al. Effect of computerized physician order entry on prescribing practices. Arch Intern Med 2000; 160: 2741-6
13. Gurwitz JH, Rochon A. Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med 2002; 162(15): 1670-2
14. Rochon A, Gurwitz JH. Prescribing for seniors: neither too much nor too little. JAMA 1999; 282 (2): 113-5
15. Ontario Ministry of Health. Ontario drug benefit formulary/comparative drug index, Toronto: Ontario Ministry of Health, 2003